KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Divestments (2022 - 2025)

Elanco Animal Health's Divestments history spans 3 years, with the latest figure at $9.0 million for Q1 2025.

  • For Q1 2025, Divestments fell 86.36% year-over-year to $9.0 million; the TTM value through Dec 2025 reached $9.0 million, down 99.34%, while the annual FY2025 figure was $9.0 million, 99.34% down from the prior year.
  • Divestments for Q1 2025 was $9.0 million at Elanco Animal Health, down from $1.3 billion in the prior quarter.
  • Across five years, Divestments topped out at $1.3 billion in Q3 2024 and bottomed at -$11.0 million in Q4 2022.
  • The 3-year median for Divestments is $37.5 million (2024), against an average of $339.5 million.
  • The largest YoY upside for Divestments was 86.36% in 2025 against a maximum downside of 86.36% in 2025.
  • A 3-year view of Divestments shows it stood at -$11.0 million in 2022, then skyrocketed by 11863.64% to $1.3 billion in 2024, then tumbled by 99.3% to $9.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Divestments are $9.0 million (Q1 2025), $1.3 billion (Q3 2024), and $66.0 million (Q1 2024).